Abstract
Purpose Glaucoma is a disorder that involves visual field loss caused by retinal ganglion cell damage. Previous diffusion magnetic resonance imaging (dMRI) studies have demonstrated that retinal ganglion cell damage affects tissues in the optic tract (OT) and optic radiation (OR). However, because previous studies have used a simple diffusion tensor model to analyze dMRI data, the microstructural interpretation of white matter tissue changes remains uncertain. In this study, we used a multi-contrast MRI approach to further clarify the type of microstructural damage that occurs in glaucoma patients.
Methods We collected multi-shell dMRI data from 17 glaucoma patients and 30 controls using 3T MRI. Using the dMRI data, we estimated three types of tissue property metrics: intracellular volume fraction (ICVF), orientation dispersion index (ODI), and isotropic volume fraction (IsoV). Quantitative T1 (qT1) data, which may be relatively specific to myelin, were collected from all subjects.
Results In the OT, all four metrics showed significant differences between the glaucoma and control groups. In the OR, only the ICVF showed significant between-group differences. ICVF was significantly correlated with qT1 in the OR of glaucoma patients, although qT1 did not show any abnormality at the group level.
Conclusions Our results suggest that at the group level, tissue changes in the glaucoma patients’ OR might be explained by axonal damage, which is reflected in the intracellular diffusion signals, rather than myelin damage. The significant correlation between ICVF and qT1 suggests that myelin damage might also occur in a smaller number of severe cases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (JP20K18396 to S.O.; JP17H04684 and JP21H03789 to H.T.; JP18K16939 to H.H.; JP20K22273 and JP21K12617 to A.M.; JP19K09982 to Y.M.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the ethics committee of the Jikei University School of Medicine, National Institute of Information and Communications Technology, and Tamagawa University. All subjects provided written informed consent to participate in the study. The study design followed the tenets of the Declaration of Helsinki.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding information: This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (JP20K18396 to S.O.; JP17H04684 and JP21H03789 to H.T.; JP18K16939 to H.H.; JP20K22273 and JP21K12617 to A.M.; JP19K09982 to Y.M.).
Commercial relationship: None.
Ethics statement: This study was approved by the ethics committee of the Jikei University School of Medicine, National Institute of Information and Communications
Technology, and Tamagawa University. This study design followed the tenets of the Declaration of Helsinki.
Data Availability
The data and code for reproducing figures and statistical analyses will become available in a public repository after an acceptance of this work in a peer-reviewed journal.
